Zwitterionic Polysulfobetaine Inhibits Cancer Cell Migration Owing to Actin Cytoskeleton Dynamics

ACS Appl Bio Mater. 2024 Jan 15;7(1):144-153. doi: 10.1021/acsabm.3c00682. Epub 2023 Dec 27.

Abstract

Cell migration is an essential dynamic process for most living cells, mainly driven by the reorganization of actin cytoskeleton. To control actin dynamics, a molecular architecture that can serve as a nucleator has been designed by polymerizing sulfobetaine methacrylate. The synthesized zwitterionic polymer, poly(sulfobetaine methacrylate) (PZI), effectively nucleates the polymerization process of G-actin and substantially accelerates the rate of polymerization. Isothermal titration calorimetry (ITC) and bioinformatics analysis indicated binding between PZI and monomeric G-actin. Thus, in vitro actin dynamics was studied by dynamic light scattering (DLS), pyrene-actin polymerization assay, and total internal reflection fluorescence microscopy (TIRFM). Furthermore, a 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) fluorophore-containing monomeric unit was incorporated into the sulfobetaine zwitterionic architecture to visualize the effect of polymer in the cellular environment. The BODIPY-containing zwitterionic sulfobetaine polymer (PZI-F) successfully penetrated the cell and remained in the lysosome with minimal cytotoxicity. Confocal microscopy revealed the influence of this polymer on the cellular actin cytoskeleton dynamics. The PZI-F polymer was successfully able to inhibit the collective migration of the human cervical cancer cell line (HeLa cell) and breast cancer cell line (MDA-MB-231 cell), as confirmed by a wound healing assay. Therefore, polyzwitterionic sulfobetaine could be explored as an inhibitor of cancer cell migration.

Keywords: BODIPY; actin cytoskeleton; cell migration; polysulfobetaine; zwitterionic polymer.

MeSH terms

  • Actin Cytoskeleton / metabolism
  • Actins* / metabolism
  • Betaine / analogs & derivatives*
  • Boron Compounds*
  • Cell Movement
  • HeLa Cells
  • Humans
  • Neoplasms*

Substances

  • Actins
  • 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
  • sulfobetaine
  • Betaine
  • Boron Compounds